A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Premature ovarian insufficiency (POI) seriously affects the physical and mental health of
women. Nowadays, Chinese herbs have huge appeal and potential in treating POI. We have
created a new Chinese herbal combination TJAOA101, whereas its safety and efficacy still need
to be validated. Hence, we will perform a population-based, multicenter study to confirm the
safety and efficacy of TJAOA101 in therapy of POI. We aim to provide a solid evidence for TCM
in therapy of POI.